Back to Search
ROBIN ZON, M.D.
M.D.
Medical Oncology Physician
NPI: 1891799391Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
01041630A(IN)4301095563(MI)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
01041630A(IN)
Research & Publications (9)
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.
PMID 19075281·J Clin Oncol·2009
6-review
American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
PMID 18390967·J Clin Oncol·2008
6-review
Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.
PMID 11561679·Invest New Drugs·2001
3-trial
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
PMID 19605506·Ann Oncol·2009
3-trial
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
PMID 19252137·J Clin Oncol·2009
6-review
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
PMID 19249063·J Urol·2009
6-review
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
PMID 19214387·Invest New Drugs·2009
3-trial
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
PMID 17062685·Clin Cancer Res·2006
3-trial
Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.
PMID 12377650·Ann Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5340 HOLY CROSS PKWY
MISHAWAKA, IN 46545 - Phone
- (574) 237-1328
Quick Facts
- NPI
- 1891799391
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 9
Are you this provider?
Claim Your Profile